{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:23:09Z","timestamp":1783574589194,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.tranon.2024.102071","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T21:04:24Z","timestamp":1722719064000},"page":"102071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Comprehensive analysis of CXCL10 and MIP-3a reveals their potential clinical application in hepatocellular carcinoma"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0928-2388","authenticated-orcid":false,"given":"Jiezuan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihong","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2024.102071_bib0001","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ijc.32723","article-title":"International trends in hepatocellular carcinoma incidence, 1978-2012","volume":"147","author":"Petrick","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tranon.2024.102071_bib0002","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S1470-2045(20)30211-4","article-title":"Combined immunotherapy and VEGF-antagonist in hepatocellular carcinoma: a step forward","volume":"21","author":"Bhoori","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.tranon.2024.102071_bib0003","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.apsb.2023.12.010","article-title":"Small-molecule agents for cancer immunotherapy","volume":"14","author":"Wang","year":"2024","journal-title":"Acta Pharm. Sin B"},{"key":"10.1016\/j.tranon.2024.102071_bib0004","article-title":"Serum cytokine and chemokine profiles and disease prognosis in hepatitis B virus-related acute-on-chronic liver failure","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2024.102071_bib0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41698-023-00428-2","article-title":"Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancers","volume":"7","author":"Romero","year":"2023","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.tranon.2024.102071_bib0006","article-title":"The CXCL family contributes to immunosuppressive microenvironment in gliomas and assists in gliomas chemotherapy","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2024.102071_bib0007","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1007\/s12094-023-03126-4","article-title":"Targeting CXCL9\/10\/11-CXCR3 axis: an important component of tumor-promoting and antitumor immunity","volume":"25","author":"Pan","year":"2023","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.tranon.2024.102071_bib0008","doi-asserted-by":"crossref","first-page":"12739","DOI":"10.2147\/OTT.S280309","article-title":"The role of CCL20-CCR6 axis in ovarian cancer metastasis","volume":"13","author":"Liu","year":"2020","journal-title":"Oncol. Targets Ther."},{"key":"10.1016\/j.tranon.2024.102071_bib0009","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13045-020-00991-2","article-title":"Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer","volume":"13","author":"Zhao","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.tranon.2024.102071_bib0010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cellimm.2018.12.010","article-title":"Epigenetic modulation enhances immunotherapy for hepatocellular carcinoma","volume":"336","author":"Hong","year":"2019","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.tranon.2024.102071_bib0011","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.7150\/ijbs.61350","article-title":"TNF-alpha augments CXCL10\/CXCR3 axis activity to induce Epithelial-Mesenchymal Transition in colon cancer cell","volume":"17","author":"Wang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.tranon.2024.102071_bib0012","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3390\/cancers15061878","article-title":"CCR7 mediates cell invasion and migration in extrahepatic cholangiocarcinoma by inducing epithelial-mesenchymal transition","volume":"15","author":"Oba","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.tranon.2024.102071_bib0013","doi-asserted-by":"crossref","first-page":"9279","DOI":"10.3748\/wjg.v22.i42.9279","article-title":"Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update","volume":"22","author":"Cong","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tranon.2024.102071_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.tranon.2024.102071_bib0015","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/hep.29922","article-title":"Cost-effectiveness of antiviral treatment after resection in hepatitis B virus-related hepatocellular carcinoma patients with compensated cirrhosis","volume":"68","author":"Xie","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.tranon.2024.102071_bib0016","doi-asserted-by":"crossref","first-page":"14879","DOI":"10.1007\/s00432-023-05265-1","article-title":"Profile and clinical significance of interferon gamma-inducible protein-10 (IP-10) and its receptor in patients with hepatocellular carcinoma","volume":"149","author":"Li","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.tranon.2024.102071_bib0017","doi-asserted-by":"crossref","first-page":"37015","DOI":"10.1038\/srep37015","article-title":"Slow reduction of IP-10 Levels predicts HBeAg seroconversion in chronic hepatitis B patients with 5 years of entecavir treatment","volume":"6","author":"Guo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2024.102071_bib0018","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: an update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia"},{"key":"10.1016\/j.tranon.2024.102071_bib0019","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.tranon.2024.102071_bib0020","doi-asserted-by":"crossref","first-page":"8846","DOI":"10.3390\/ijms23168846","article-title":"Chemokines in primary liver cancer","volume":"23","author":"Zajkowska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2024.102071_bib0021","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3390\/vaccines11081357","article-title":"A comprehensive review on cancer vaccines and vaccine strategies in hepatocellular carcinoma","volume":"11","author":"Tojjari","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.tranon.2024.102071_bib0022","doi-asserted-by":"crossref","first-page":"8548","DOI":"10.3390\/ijms24108548","article-title":"Multiparametric dynamic ultrasound approach for differential diagnosis of primary liver tumors","volume":"24","author":"Ainora","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2024.102071_bib0023","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1111\/liv.14687","article-title":"Recent advances targeting C-C chemokine receptor type 2 for liver diseases in monocyte\/macrophage","volume":"40","author":"Li","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.tranon.2024.102071_bib0024","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.biopha.2016.04.069","article-title":"CXCL10\/CXCR3 axis promotes the invasion of gastric cancer via PI3K\/AKT pathway-dependent MMPs production","volume":"82","author":"Zhou","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tranon.2024.102071_bib0025","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3390\/ijms20051194","article-title":"Nuclear ERK: mechanism of translocation, substrates, and role in cancer","volume":"20","author":"Maik-Rachline","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2024.102071_bib0026","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jhep.2016.05.032","article-title":"CXCL10\/CXCR3 signaling mobilized-regulatory T cells promote liver tumor recurrence after transplantation","volume":"65","author":"Li","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tranon.2024.102071_bib0027","doi-asserted-by":"crossref","first-page":"778","DOI":"10.4149\/neo_2017_517","article-title":"Identification of chemokine CXCL10 in tumor microenvironment by antibody array as a prognostic marker in hepatocellular carcinoma","volume":"64","author":"Li","year":"2017","journal-title":"Neoplasma"},{"key":"10.1016\/j.tranon.2024.102071_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.896099","article-title":"Insights into the role of matrix metalloproteinases in cancer and its various therapeutic aspects: a review","volume":"9","author":"Mustafa","year":"2022","journal-title":"Front Mol. Biosci."},{"key":"10.1016\/j.tranon.2024.102071_bib0029","first-page":"2824","article-title":"CXCL10 accelerates EMT and metastasis by MMP-2 in hepatocellular carcinoma","volume":"9","author":"Ren","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.tranon.2024.102071_bib0030","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1111\/liv.14581","article-title":"TP53 R249S mutation detected in circulating tumour DNA is associated with Prognosis of hepatocellular carcinoma patients with or without hepatectomy","volume":"40","author":"Shen","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.tranon.2024.102071_bib0031","article-title":"An inflammation-related gene landscape predicts prognosis and response to immunotherapy in virus-associated hepatocellular carcinoma","volume":"13","author":"Gao","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2024.102071_bib0032","doi-asserted-by":"crossref","first-page":"972","DOI":"10.14218\/JCTH.2021.00443","article-title":"HBeAg-negative patients with chronic hepatitis B virus infection and normal alanine aminotransferase: wait or treat?","volume":"10","author":"Sheng","year":"2022","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.tranon.2024.102071_bib0033","first-page":"129","article-title":"Circulating BAFF and CXCL10 levels predict response to pegylated interferon in patients with HBeAg-positive chronic hepatitis B","volume":"39","author":"Khlaiphuengsin","year":"2021","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.tranon.2024.102071_bib0034","article-title":"Ongoing involvers and promising therapeutic targets of hepatic fibrosis: the hepatic immune microenvironment","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2024.102071_bib0035","doi-asserted-by":"crossref","first-page":"8112","DOI":"10.3390\/ijms23158112","article-title":"Chemokine CXCL10 modulates the tumor microenvironment of fibrosis-associated hepatocellular carcinoma","volume":"23","author":"Brandt","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2024.102071_bib0036","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.2217\/fon-2018-0087","article-title":"Alkaline phosphatase in metastatic castration-resistant prostate cancer: reassessment of an older biomarker","volume":"14","author":"Heinrich","year":"2018","journal-title":"Future Oncol."},{"key":"10.1016\/j.tranon.2024.102071_bib0037","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.biopha.2017.01.046","article-title":"COMMD7 promotes hepatocellular carcinoma through regulating CXCL10","volume":"88","author":"You","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tranon.2024.102071_bib0038","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.canlet.2021.03.002","article-title":"Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10\/CXCR3 axis in hepatocellular carcinoma (HCC)","volume":"506","author":"Yan","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tranon.2024.102071_bib0039","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.3390\/ijms24065295","article-title":"Serum CXCL5 detects early hepatocellular carcinoma and indicates tumor progression","volume":"24","author":"Laschtowitz","year":"2023","journal-title":"Int. J. Mol. Sci."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523324001980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523324001980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T21:49:26Z","timestamp":1723326566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523324001980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":39,"alternative-id":["S1936523324001980"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2024.102071","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive analysis of CXCL10 and MIP-3a reveals their potential clinical application in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2024.102071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. CCBYLICENSE","name":"copyright","label":"Copyright"}],"article-number":"102071"}}